MedPath

Uterus Transplantation From Live Donor

Not Applicable
Completed
Conditions
Primary Uterine Infertility
Interventions
Procedure: uterine transplantation
Registration Number
NCT01844362
Lead Sponsor
Sahlgrenska University Hospital, Sweden
Brief Summary

Uterus transplantation, as a possible future treatment for uterine factor infertility, has been developed in animal species during the last decade.

The study protocol includes transplantation of the uterus from a live donor (mother, relative, friend) into women with absolute uterine factor infertility (lack of uterus from birth or due to life saving hysterectomy).The recipient will be treated by standard immunosuppression and transfer of embryos (acquired by IVF before surgery) will be attempted when at least 12 months have passed from transplantation. Approval for a case series including up to 10 patients has been acquired.

Detailed Description

The study is ongoing, with inclusion of 9 patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
9
Inclusion Criteria
  • less than 39 years
  • good general health
Exclusion Criteria
  • poor ovarian resaerve or older than 39 years
  • systemic or psychiatric disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Uterine transplantationuterine transplantationPatients undergo transplantation of the uterus from live donor.
Primary Outcome Measures
NameTimeMethod
surviving transplants (12 months)up to 3 years after transplantation
Secondary Outcome Measures
NameTimeMethod
pregnancy rateup to 3 years after transplantation

Trial Locations

Locations (1)

Mats Brännström

🇸🇪

Göteborg, Sweden

© Copyright 2025. All Rights Reserved by MedPath